Cite
HARVARD Citation
Doria, A. et al. (n.d.). SAT0231 Safety of subcutaneous belimumab in patients with systemic lupus erythematosus: a 6-month open-label extension study. Annals of the rheumatic diseases. p. 861. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Doria, A. et al. (n.d.). SAT0231 Safety of subcutaneous belimumab in patients with systemic lupus erythematosus: a 6-month open-label extension study. Annals of the rheumatic diseases. p. 861. [Online].